Diabetes News

There is a new, potential alternative for many of the more than 5 million Americans who take insulin injections, with the Food and Drug Administration's approval today of the first ever inhaled insulin.

Study of NYC pharmacies found that only 69 percent have the ability to provide prescription labels in Spanish and that pharmacists only do so upon customer request.

Sulfonylurea drugs, used in the treatment of patients with diabetes mellitus to lower blood sugar levels, have been suspected since the 1970s of increasing cardiovascular mortality as well.

Research on one promising new treatment uses a growing body of evidence that inflammation may be a key cause of diabetic kidney disease.

Obese and overweight individuals suffering metabolic syndrome and Type 2 diabetes showed significant health improvements after only three weeks of diet and moderate exercise even though the participants remained overweight.

The brain plays a major role in the ability of insulin therapy to lower blood sugar in animals with diabetes, according to a new study.

While their findings could provide new insight into mammalian hibernation, researchers note that the pivotal metabolic signal that emerged from the dark also presents a new target for obesity and type 2 diabetes research.

Roche Diagnostics has initiated a worldwide voluntary recall of specific ACCU-CHEK Aviva Meters because of the potential for an electronic malfunction which can cause the meter to report an erroneous result or shut down and no longer be used.

GlaxoSmithKline and FDA notified healthcare professionals about post-marketing reports of new onset and worsening diabetic macular edema for patients receiving rosiglitazone.

Amid mounting concerns about the ethics and limitations of animal use in laboratories, the PCRM announced that it has developed a diagnostic test used to measure insulin levels in diabetes patients.

A growing number of women are overweight or obese when they become pregnant, a condition that is risky to both mother and baby.

Higher insulin concentrations and insulin resistance are associated with an increased risk of pancreatic cancer in men.

A study has identified a protein that appears to play a key role in protecting neurons from oxidative stress, a toxic process linked to neurodegenerative illnesses including Alzheimer's and Parkinson's diseases.

Roche Diagnostics has voluntarily sent people with diabetes, physicians, and pharmacists a letter informing them of a recall of some of its ACCU-CHEK Aviva blood glucose meters.

Researchers have discovered that insulin and its receptors drop significantly in the brain during the early stages of Alzheimer's disease, and that levels decline progressively as the disease becomes more severe, leading to further evidence that Alzheimer's is a new type of diabetes.

Researchers are using a new cell transplantation technique to restore the cells that produce insulin in patients with type 1 diabetes.